ARCHIVES

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 25 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Healy’s Boxes Packed, When Word Came That She Could Stay

January 29, 1993

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011